Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12608000440325Phase 4Completed
Phase 4, open-label trial of influenza vaccine in influenza (2 arms), sponsored by Royal Adelaide Hospital. Primary endpoint: Immunological response to influenza vaccine. Started Apr 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12608000440325.